Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study
加拿大魁北克省33至35周胎龄婴儿呼吸道合胞病毒（RSV）住院率受帕利珠单抗免疫预防撤药影响的研究：RSV-魁北克研究
期刊:Journal of the Pediatric Infectious Diseases Society
影响因子:2.6
doi:10.1093/jpids/piaa046
Papenburg, Jesse; Defoy, Isabelle; Massé, Edith; Caouette, Georges; Lebel, Marc H
